Overview

Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic Syndromes

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
To determine if H.P. Acthar Gel (repository corticotrophin) has the same anti-proteinuric effects seen with the synthetic ACTH analogue in Europe.
Phase:
Phase 4
Details
Lead Sponsor:
Arizona Kidney Disease and Hypertension Center
Treatments:
Adrenocorticotropic Hormone